Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Journal of Pharmaceutical Sciences
|
June 1, 1980
Quantitation of the antineoplastic agent indicine-N-oxide in human plasma by differential pulse polarography
M McComish, I Bodek, A R Branfman
Progress in Clinical and Biological Research
|
January 1, 1984
Human disposition and some biochemical aspects of methylxanthines
D W Yesair, A R Branfman, M M Callahan
Cancer Treatment Reports
|
May 1, 1979
Determination of N-(Phosphonacetyl)-L-aspartic acid (PALA) in dog serum and urine by gas chromatography and selected lon monitoring
J M Strong, Y E Kinney, A R Branfman, et al.
Science (New York, N.Y.)
|
February 23, 1976
Antileukemic principles isolated from euphorbiaceae plants
S M Kupchan, I Uchida, A R Branfman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 1, 1978
Characterization of the metabolites of ellipticine in rat bile
A R Branfman, R J Bruni, V N Reinhold, et al.
Cancer Research
|
February 1, 1982
Comparative physiological disposition of N-(phosphonacetyl)-L-aspartate in several animal species after intravenous and oral administration
M Chadwick, D M Silveira, J A MacGregor, et al.
Journal of Chromatography
|
May 9, 1980
Quantitation of the antitumor agent N-(phosphonacetyl)-L-aspartic acid in human plasma and urine by gas chromatography-mass spectrometry-selected ion monitoring
A R Branfman, R J Bruni, Y N Merrill, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 1, 1983
Characterization of diaminouracil metabolites of caffeine in human urine
A R Branfman, M F McComish, R J Bruni, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 1, 1982
Human metabolism of [1-methyl-14C]- and [2-14C]caffeine after oral administration
M M Callahan, R S Robertson, M J Arnaud, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1982
A phase I trial of combination therapy with continuous-infusion PALA and continuous-infusion 5-FU
G R Weiss, T J Ervin, M W Meshad, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Journal of Pharmaceutical Sciences
|
June 1, 1980
Quantitation of the antineoplastic agent indicine-N-oxide in human plasma by differential pulse polarography
M McComish, I Bodek, A R Branfman
Progress in Clinical and Biological Research
|
January 1, 1984
Human disposition and some biochemical aspects of methylxanthines
D W Yesair, A R Branfman, M M Callahan
Cancer Treatment Reports
|
May 1, 1979
Determination of N-(Phosphonacetyl)-L-aspartic acid (PALA) in dog serum and urine by gas chromatography and selected lon monitoring
J M Strong, Y E Kinney, A R Branfman, et al.
Science (New York, N.Y.)
|
February 23, 1976
Antileukemic principles isolated from euphorbiaceae plants
S M Kupchan, I Uchida, A R Branfman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 1, 1978
Characterization of the metabolites of ellipticine in rat bile
A R Branfman, R J Bruni, V N Reinhold, et al.
Cancer Research
|
February 1, 1982
Comparative physiological disposition of N-(phosphonacetyl)-L-aspartate in several animal species after intravenous and oral administration
M Chadwick, D M Silveira, J A MacGregor, et al.
Journal of Chromatography
|
May 9, 1980
Quantitation of the antitumor agent N-(phosphonacetyl)-L-aspartic acid in human plasma and urine by gas chromatography-mass spectrometry-selected ion monitoring
A R Branfman, R J Bruni, Y N Merrill, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 1, 1983
Characterization of diaminouracil metabolites of caffeine in human urine
A R Branfman, M F McComish, R J Bruni, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 1, 1982
Human metabolism of [1-methyl-14C]- and [2-14C]caffeine after oral administration
M M Callahan, R S Robertson, M J Arnaud, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1982
A phase I trial of combination therapy with continuous-infusion PALA and continuous-infusion 5-FU
G R Weiss, T J Ervin, M W Meshad, et al.
Page
of 2